Rhonda Patrick· PhD
So we know from the Australian nicotenomide trials that supplementing with you know the classic NAD booster nicotenomide um lowers cancer risk at the population level.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So we know from the Australian nicotenomide trials that supplementing with you know the classic NAD booster nicotenomide um lowers cancer risk at the population level.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Um but overall the clinical data say that NAD boosting is preventative for cancer and that niggen is safe.